Abstract
Recurrent Aphthous Stomatitis (RAS), which has symptoms like pain while
eating, speaking, or swallowing, is one of the most hurtful oral mucosal inflammatory
ulcerative diseases [1]. Tumor necrosis factor α (TNF α), has a main role in
predominantly cell-mediated immune response due to the pathogenesis of RAS. The
aim of this study was to investigate the therapeutic effects of Beta-glucan on the
response of lymphocytes with and without phytohemagglutinin (PHA), a T lymphocyte
mitogen, in treatment of RAS. RAS, estimated by the Ulcer Severity Score (USS),
shows ulcer characteristics (number, size, duration, ulcer-free period, site, and pain).
Keywords: Beta Glucan, Diabetic Ulcers, Recurrent Aphthous Stomatitis.
Related Journals
Current Clinical Pharmacology
Current Cancer Therapy Reviews
Current Nanomedicine
Current Psychopharmacology
Drug Delivery Letters
Letters in Drug Design & Discovery
Recent Advances in Anti-Infective Drug Discovery
Coronaviruses
Applied Drug Research, Clinical Trials and Regulatory Affairs
Anti-Infective Agents
Related Books
Bioactive Phytochemicals: Drug Discovery to Product Development
Biologically Active Natural Products from Asia and Africa: A Selection of Topics
Endocannabinoids: Molecular, Pharmacological, Behavioral and Clinical Features
Nanotechnology Driven Herbal Medicine for Burns: From Concept to Application
Postbiotics: Science, Technology and Applications
Solubility, Delivery and ADME Problems of Drugs and Drug-Candidates
The Pharmaceutical Scientist Guide to Solution Kinetic Models Mathematical Description and Applications
Evidence-Based Research in Ayurveda against COVID-19 in Compliance with Standardized Protocols and Practices
Pharmaceutical Chemistry and Production: An Introductory Textbook
